electroCore Inc

ECOR

Company Profile

  • Business description

    electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

  • Contact

    200 Forge Way
    Suite 205
    RockawayNJ07866
    USA

    T: +1 973 290-0097

    E: [email protected]

    https://www.electrocore.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    62

Stocks News & Analysis

stocks

Undervalued ASX income play

Major development projects remain on schedule.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock
stocks

Going into earnings, Is Meta stock a buy, a sell, or fairly valued?

With a focus on leveraging its AI investments, here’s what we think of Meta stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,926.2080.60-0.89%
CAC 407,798.2224.45-0.31%
DAX 4024,307.8018.290.08%
Dow JONES (US)44,323.0719.12-0.04%
FTSE 1009,012.9920.870.23%
HKSE24,994.14168.480.68%
NASDAQ20,974.1878.520.38%
Nikkei 22539,819.1182.08-0.21%
NZX 50 Index12,961.5181.110.63%
S&P 5006,305.608.810.14%
S&P/ASX 2008,668.2089.00-1.02%
SSE Composite Index3,559.7925.310.72%

Market Movers